"What we're seeing for the first time is that curve is bending and shows a sign of hope for something that was really a threat to American public health for so many years," said study co-author John Brownstein.
Brownstein and his team noted that women and adults aged 66 to 75 saw the largest decreases in obesity. People living in the South, where they had the highest dispensing rate of weight loss drugs known as GLP-1 receptor agonists, also saw a meaningful decline in obesity.
Collection
[
|
...
]